These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16038622)

  • 1. Oxidative stress and stress signaling: menace of diabetic cardiomyopathy.
    Wold LE; Ceylan-Isik AF; Ren J
    Acta Pharmacol Sin; 2005 Aug; 26(8):908-17. PubMed ID: 16038622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress: a key contributor to diabetic cardiomyopathy.
    Khullar M; Al-Shudiefat AA; Ludke A; Binepal G; Singal PK
    Can J Physiol Pharmacol; 2010 Mar; 88(3):233-40. PubMed ID: 20393588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of vascular reactive oxygen species in development of vascular abnormalities in diabetes.
    Son SM
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S65-70. PubMed ID: 17467110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of vitamin E in type 2 diabetes mellitus.
    Fardoun RZ
    Clin Exp Hypertens; 2007 Apr; 29(3):135-48. PubMed ID: 17497341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive species and diabetes: counteracting oxidative stress to improve health.
    Pérez-Matute P; Zulet MA; Martínez JA
    Curr Opin Pharmacol; 2009 Dec; 9(6):771-9. PubMed ID: 19766058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of antioxidants in diabetes-induced cardiac dysfunction.
    Vassort G; Turan B
    Cardiovasc Toxicol; 2010 Jun; 10(2):73-86. PubMed ID: 20458637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress as the leading cause of acute myocardial infarction in diabetics.
    Di Filippo C; Cuzzocrea S; Rossi F; Marfella R; D'Amico M
    Cardiovasc Drug Rev; 2006; 24(2):77-87. PubMed ID: 16961722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review on the role of antioxidants in the management of diabetes and its complications.
    Rahimi R; Nikfar S; Larijani B; Abdollahi M
    Biomed Pharmacother; 2005 Aug; 59(7):365-73. PubMed ID: 16081237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
    Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
    J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and antioxidant treatment in diabetes.
    Scott JA; King GL
    Ann N Y Acad Sci; 2004 Dec; 1031():204-13. PubMed ID: 15753146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy.
    Cai L
    Free Radic Biol Med; 2006 Sep; 41(6):851-61. PubMed ID: 16934665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress, diabetes, and diabetic complications.
    Wei W; Liu Q; Tan Y; Liu L; Li X; Cai L
    Hemoglobin; 2009; 33(5):370-7. PubMed ID: 19821780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of haemodialysis on the oxidative stress and antioxidants in diabetes mellitus.
    Dursun E; Dursun B; Suleymanlar G; Ozben T
    Acta Diabetol; 2005 Oct; 42(3):123-8. PubMed ID: 16258735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes.
    Pelletier A; Coderre L
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1325-32. PubMed ID: 17227964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and diabetic cardiovascular complications.
    Jay D; Hitomi H; Griendling KK
    Free Radic Biol Med; 2006 Jan; 40(2):183-92. PubMed ID: 16413400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic cardiomyopathy revisited.
    Boudina S; Abel ED
    Circulation; 2007 Jun; 115(25):3213-23. PubMed ID: 17592090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress detection: what for? Part II.
    Palmieri B; Sblendorio V
    Eur Rev Med Pharmacol Sci; 2007; 11(1):27-54. PubMed ID: 17405347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipotoxicity in type 2 diabetic cardiomyopathy.
    van de Weijer T; Schrauwen-Hinderling VB; Schrauwen P
    Cardiovasc Res; 2011 Oct; 92(1):10-8. PubMed ID: 21803867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications.
    Colak E; Majkić-Singh N; Stanković S; Srecković-Dimitrijević V; Djordjević PB; Lalić K; Lalić N
    Ann Med; 2005; 37(8):613-20. PubMed ID: 16338763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review.
    El Haouari M; Rosado JA
    Blood Cells Mol Dis; 2008; 41(1):119-23. PubMed ID: 18387322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.